The IC50 was calculated for each of the cell lines from the data presented in Figure 1 and is shown in micromoles
Line . | IC50, μM . |
---|---|
Human pre T-LBL cell lines | |
KOP-TK1 | 0.83 |
MOLT16 | 0.83 |
ALL-SIL | 2.78 |
HPB-ALL | 3.89 |
TALL-1 | 4.17 |
HSB2 | 7.78 |
Jurkat | 8.89 |
CEM | 15.0 |
DU528 | 15.0 |
SUPT11 | 27.5 |
Human non-T leukemic cell lines | |
MV4-11 | 3.89 |
Nalm6 | 9.17 |
Kasumi1 | 12.8 |
HEL | 16.9 |
U937 | 21.4 |
NB4 | 22.2 |
HL60 | 24.4 |
THP1 | 28.1 |
K562 | 39.7 |
Murine leukemic cell lines | |
12/1 | 3.06 |
6645/4 | 3.38 |
6605/4 | 3.61 |
6812/2 | 6.67 |
St4113 | 6.67 |
F4-6 | 14.4 |
Line . | IC50, μM . |
---|---|
Human pre T-LBL cell lines | |
KOP-TK1 | 0.83 |
MOLT16 | 0.83 |
ALL-SIL | 2.78 |
HPB-ALL | 3.89 |
TALL-1 | 4.17 |
HSB2 | 7.78 |
Jurkat | 8.89 |
CEM | 15.0 |
DU528 | 15.0 |
SUPT11 | 27.5 |
Human non-T leukemic cell lines | |
MV4-11 | 3.89 |
Nalm6 | 9.17 |
Kasumi1 | 12.8 |
HEL | 16.9 |
U937 | 21.4 |
NB4 | 22.2 |
HL60 | 24.4 |
THP1 | 28.1 |
K562 | 39.7 |
Murine leukemic cell lines | |
12/1 | 3.06 |
6645/4 | 3.38 |
6605/4 | 3.61 |
6812/2 | 6.67 |
St4113 | 6.67 |
F4-6 | 14.4 |
IC50 indicates 50% inhibitory concentration; and pre-T-LBL, precursor T-cell lymphoblastic leukemia/lymphoma.